Literature DB >> 12083802

Nucleolar localization of hTERT protein is associated with telomerase function.

Yinhua Yang1, Yaohui Chen, Chunyu Zhang, Hai Huang, Sherman M Weissman.   

Abstract

Telomerase is a ribonucleoprotein (RNP) complex that prevents telomeric erosion in eukaryotic cells. Although there are also other associated proteins in this complex, the catalytic activity of this complex is composed of two components. One is a reverse transcriptase subunit, TERT (telomerase reverse transcriptase); another is an RNA template subunit, TR (telomerase RNA). However, where these two parts are assembled in mammalian cells is unclear. In the present study, we investigated the intracellular distribution of human TERT (hTERT) protein and observed that hTERT protein in individual cells could concentrate in or be excluded from the nucleolus. Further we have identified a nucleolar targeting signal in the hTERT protein. Point mutations that disrupted this signal region interrupted telomerase RNP complex formation, decreased telomerase activity, and caused telomere shortening in cells transfected with mutated hTERT. Our results indicate that the amino acid sequence of the extreme N-terminus (1-15) of hTERT, which targets nucleolar localization of the protein, is required for full telomerase function. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083802     DOI: 10.1006/excr.2002.5541

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  Cell cycle-regulated trafficking of human telomerase to telomeres.

Authors:  Rebecca L Tomlinson; Tania D Ziegler; Teerawit Supakorndej; Rebecca M Terns; Michael P Terns
Journal:  Mol Biol Cell       Date:  2005-12-07       Impact factor: 4.138

2.  Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres.

Authors:  Beáta E Jády; Patricia Richard; Edouard Bertrand; Tamás Kiss
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

Review 3.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

4.  MicroRNA-206 colocalizes with ribosome-rich regions in both the nucleolus and cytoplasm of rat myogenic cells.

Authors:  Joan C Ritland Politz; Fan Zhang; Thoru Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-29       Impact factor: 11.205

5.  Progression of astrocytomas and meningiomas: an evaluation in vitro.

Authors:  L Maes; J P O Kalala; M Cornelissen; L de Ridder
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

6.  Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy.

Authors:  Ioannis Zachos; Panagiotis A Konstantinopoulos; Gerasimos P Vandoros; Michalis V Karamouzis; Athanasios G Papatsoris; Thomas Podimatas; Antonios Papachristodoulou; Michael Chrisofos; Charalambos Deliveliotis; Athanasios G Papavassiliou
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-12       Impact factor: 4.553

7.  Telomerase trafficking and assembly in Xenopus oocytes.

Authors:  Zhu-Hong Li; Rebecca L Tomlinson; Rebecca M Terns; Michael P Terns
Journal:  J Cell Sci       Date:  2010-07-15       Impact factor: 5.285

Review 8.  The Cajal body and the nucleolus: "In a relationship" or "It's complicated"?

Authors:  Laura Trinkle-Mulcahy; Judith E Sleeman
Journal:  RNA Biol       Date:  2016-09-23       Impact factor: 4.652

9.  Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.

Authors:  Qing-You Du; Xiao-Bo Wang; Xue-Jun Chen; Wei Zheng; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.

Authors:  Sylvain Huard; Tara J Moriarty; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.